[
    {
      "id":"medqa,0",
      "type":"mc",
      "conversations":[
        {
          "from":"human",
          "value":"A 23-year-old pregnant woman at 22 weeks gestation presents with burning upon urination. She states it started 1 day ago and has been worsening despite drinking more water and taking cranberry extract. She otherwise feels well and is followed by a doctor for her pregnancy. Her temperature is 97.7\u00b0F (36.5\u00b0C), blood pressure is 122/77 mmHg, pulse is 80/min, respirations are 19/min, and oxygen saturation is 98% on room air. Physical exam is notable for an absence of costovertebral angle tenderness and a gravid uterus. Which of the following is the best treatment for this patient?\n\nA. Ampicillin\nB. Ceftriaxone\nC. Doxycycline\nD. Nitrofurantoin"
        },
        {
          "from":"gpt",
          "value":"The answer is D."
        }
      ],
      "answer":"D",
      "model_outputs":[
        {
          "BioMistral-7B-Zephyr-Beta-SLERP_base":" The patient presents with burning upon urination, which is a common symptom of urinary tract infection (UTI). UTIs are more common during pregnancy due to the increased urinary frequency and decreased immune function. The most common pathogens causing UTIs during pregnancy are Escherichia coli, Enterococcus faecalis, and Group B streptococcus. \n\nThe patient is pregnant at 22 weeks gestation, which is considered the second trimester. During the second trimester, antibiotic choices should be based on the severity of the infection and the patient's history. \n\nGiven that this patient's symptoms started suddenly and have worsened despite drinking more water and taking cranberry extract, it suggests a more severe infection. Therefore, oral antibiotics would be the appropriate treatment. \n\nNitrofurantoin is contraindicated in pregnancy due to its potential teratogenic effects. Ampicillin and doxycycline should also be avoided during pregnancy due to their potential for dental discoloration in the developing fetus. \n\nCeftriaxone is a safe choice for pregnant patients with UTIs and is recommended by the American College of Obstetricians and Gynecologists (ACOG). \n\nSo, the answer is B."
        },
        {
          "med42-70b_base":" Nitrofurantoin is the best treatment option for this patient. It is commonly used for treating asymptomatic bacteriuria, which is a common occurrence in pregnant women. The other antibiotics listed (ampicillin, ceftriaxone, and doxycycline) are not appropriate for treating this condition in pregnancy due to potential adverse effects on the fetus."
        },
        {
          "Mixtral-8x7B-Instruct-v0.1_base":" The patient is a pregnant woman presenting with dysuria (burning upon urination) and no costovertebral angle tenderness. This suggests an uncomplicated lower urinary tract infection (UTI), which is common during pregnancy. The best treatment option for an uncomplicated lower UTI in pregnancy is nitrofurantoin (D). Ampicillin (A) is not the first-line treatment for UTIs due to increasing bacterial resistance. Ceftriaxone (B) is typically used for pyelonephritis (complicated UTI) or for patients who are allergic to first-line agents. Doxycycline (C) is contraindicated in pregnancy due to potential teratogenic effects.\n\nSo, the answer is D."
        },
        {
          "Qwen1.5-72B-Chat_base":"The patient's symptoms of burning upon urination suggest a urinary tract infection (UTI), which is common in pregnant women. Given that there is no costovertebral angle tenderness (a sign of pyelonephritis, a more severe kidney infection), the infection is likely limited to the bladder (cystitis).\n\nThe treatment for a pregnant woman with a simple UTI typically involves an antibiotic that is safe for both the mother and the fetus. Nitrofurantoin (D) is a common choice for this purpose as it is effective against many urinary pathogens and has a low risk of resistance. It is also less likely to cause side effects in the mother or harm the developing fetus compared to other antibiotics.\n\nAmpicillin (A) might be an alternative, but it is not the first-line choice for UTIs anymore due to increased resistance. Ceftriaxone (B) is usually reserved for more severe or complicated infections, and Doxycycline (C) is contraindicated in pregnancy due to potential harm to the fetus.\n\nSo, the answer is D."
        },
        {
          "gpt-3.5-turbo-1106":"The patient's symptoms, including burning upon urination, are consistent with a urinary tract infection (UTI). Given that she is pregnant, it is important to choose an antibiotic that is safe for both her and the fetus. Nitrofurantoin is the preferred choice for treating UTIs in pregnancy, as it has a good safety profile and is effective against the most common pathogens causing UTIs. Therefore, the best treatment for this patient would be nitrofurantoin.\n\nSo, the answer is D. Nitrofurantoin"
        },
        {
          "gpt-4-1106-preview":"The clinical scenario suggests that the pregnant woman is likely experiencing a urinary tract infection (UTI), given her symptoms of burning upon urination. During pregnancy, the risk of UTIs increases due to physiological changes, and it is important to treat them to prevent complications such as pyelonephritis or preterm labor.\n\nWhen considering antibiotic therapy for a UTI in a pregnant woman, it's crucial to choose an agent that is safe for both the mother and the fetus. Let's evaluate the options:\n\nA. Ampicillin - This is a penicillin antibiotic that is generally considered safe during pregnancy and can be used to treat UTIs. However, it may not be the first choice due to resistance patterns.\n\nB. Ceftriaxone - This is a cephalosporin antibiotic that is also generally safe in pregnancy and effective against a broad range of bacteria. It is typically used for more complicated infections or when other antibiotics are not suitable.\n\nC. Doxycycline - This is a tetracycline antibiotic that is contraindicated during pregnancy because it can affect fetal bone growth and discoloration of teeth.\n\nD. Nitrofurantoin - This antibiotic is commonly used to treat uncomplicated UTIs and is considered safe during most of the pregnancy. However, it is not recommended at the very end of pregnancy (after 38 weeks) due to the risk of hemolytic anemia in the newborn.\n\nGiven that the patient is at 22 weeks gestation and has an uncomplicated UTI, the best choice would be an antibiotic that is safe and commonly used for UTIs in pregnancy.\n\nSo, the answer is D. Nitrofurantoin."
        }
      ]
    },
    {
      "id":"medqa,1",
      "type":"mc",
      "conversations":[
        {
          "from":"human",
          "value":"A 3-month-old baby died suddenly at night while asleep. His mother noticed that he had died only after she awoke in the morning. No cause of death was determined based on the autopsy. Which of the following precautions could have prevented the death of the baby?\n\nA. Placing the infant in a supine position on a firm mattress while sleeping\nB. Keeping the infant covered and maintaining a high room temperature\nC. Application of a device to maintain the sleeping position\nD. Avoiding pacifier use during sleep"
        },
        {
          "from":"gpt",
          "value":"The answer is A."
        }
      ],
      "answer":"A",
      "model_outputs":[
        {
          "BioMistral-7B-Zephyr-Beta-SLERP_base":" The baby died suddenly while sleeping. No cause of death was determined based on the autopsy. This could mean that the baby died of sudden infant death syndrome (SIDS), which is the leading cause of death in infants between 1 month and 1 year of age. SIDS is defined as the sudden unexplained death of an infant under 1 year of age that remains unexplained after a thorough investigation, including a complete autopsy, examination of the death scene, and review of the clinical history.\n\nTo prevent SIDS, the American Academy of Pediatrics (AAP) recommends placing the baby in a supine position on a firm mattress while sleeping. This recommendation is based on extensive research that shows that placing infants to sleep on their back reduces the risk of SIDS by more than 50%. In addition, the AAP recommends keeping the infant covered and maintaining a high room temperature to prevent overheating, which is a risk factor for SIDS. The use of pacifiers may also reduce the risk of SIDS, but only when used during sleep. Finally, devices to maintain the sleeping position are not recommended as they can pose a suffocation risk and have not been shown to be effective in preventing SIDS.\n\nSo, the answer is A."
        },
        {
          "med42-70b_base":" The sudden death of an infant during sleep with no determined cause is typically referred to as Sudden Infant Death Syndrome (SIDS).\n\nOption A: Placing the infant in a supine position on a firm mattress while sleeping is recommended to prevent SIDS, as it reduces the risk of the baby's airway becoming blocked.\n\nOption B: Keeping the infant covered and maintaining a high room temperature might increase the risk of SIDS, as overheating is a known risk factor.\n\nOption C: Application of a device to maintain the sleeping position might not be effective in preventing SIDS, as it doesn't address the main risk factors.\n\nOption D: Avoiding pacifier use during sleep has some evidence of reducing the risk of SIDS, but it is not as significant as placing the infant in a supine position on a firm mattress.\n\nSo, the answer is A."
        },
        {
          "Mixtral-8x7B-Instruct-v0.1_base":" The scenario described suggests a case of Sudden Infant Death Syndrome (SIDS), which is the unexplained death, usually during sleep, of a seemingly healthy baby less than a year old. \n\nThe exact cause of SIDS is unknown, but it's thought to be down to a combination of factors. Experts believe SIDS might be associated with defects in the portion of an infant's brain that controls breathing and arousal from sleep.\n\nIn 1992, the American Academy of Pediatrics (AAP) recommended that babies should be placed on their backs to sleep, to reduce the risk of SIDS. This is based on substantial evidence that stomach sleeping can increase the risk of SIDS.\n\nBased on this information, the correct answer is:\n\nSo, the answer is A."
        },
        {
          "Qwen1.5-72B-Chat_base":"A. Placing the infant in a supine position on a firm mattress while sleeping is a well-known precaution to reduce the risk of sudden infant death syndrome (SIDS) or sudden unexpected infant death (SUID). This position is recommended by pediatricians and health organizations worldwide because it helps minimize the risk of suffocation and airway obstruction.\n\nB. Keeping the infant covered and maintaining a high room temperature can actually increase the risk of SIDS, as overheating has been associated with an increased risk of SIDS.\n\nC. Application of a device to maintain the sleeping position might seem helpful, but it is not a recommended practice to prevent SIDS. The American Academy of Pediatrics (AAP) suggests that simple positioning, such as placing the baby on their back, is sufficient.\n\nD. Avoiding pacifier use during sleep has not been shown to be a necessary precaution for SIDS prevention. On the contrary, the use of a pacifier during sleep has been associated with a reduced risk of SIDS, although the exact mechanism is not fully understood.\n\nGiven these considerations, the most important and evidence-based precaution to prevent sudden infant death is placing the baby in a supine position on a firm surface.\n\nSo, the answer is A."
        },
        {
          "gpt-3.5-turbo-1106":"First, placing the infant in a supine position on a firm mattress while sleeping is recommended to reduce the risk of sudden infant death syndrome (SIDS). This position allows for better airflow and reduces the risk of suffocation.\n\nSecond, keeping the infant covered and maintaining a high room temperature is not recommended as it can increase the risk of overheating, which is a risk factor for SIDS.\n\nThird, application of a device to maintain the sleeping position is not recommended as it can increase the risk of suffocation or entrapment.\n\nFinally, avoiding pacifier use during sleep is not recommended as pacifier use has been associated with a reduced risk of SIDS.\n\nSo, the answer is A. Placing the infant in a supine position on a firm mattress while sleeping."
        },
        {
          "gpt-4-1106-preview":"The scenario described is suggestive of Sudden Infant Death Syndrome (SIDS), which is the sudden, unexplained death of a baby younger than one year of age that doesn't have a known cause even after a complete investigation, including an autopsy.\n\nNow, let's evaluate the options:\n\nA. Placing the infant in a supine position on a firm mattress while sleeping - This is a known recommendation to reduce the risk of SIDS. Babies should be placed on their backs for every sleep.\n\nB. Keeping the infant covered and maintaining a high room temperature - This is not recommended. Overheating has been associated with an increased risk of SIDS. The baby should be kept at a comfortable temperature, and the room should not be too hot.\n\nC. Application of a device to maintain the sleeping position - Devices marketed to maintain sleep position are not recommended for infants. They have not been shown to be effective at preventing SIDS and can actually increase the risk of suffocation.\n\nD. Avoiding pacifier use during sleep - This is incorrect. Some studies have shown that pacifier use during sleep can actually reduce the risk of SIDS.\n\nSo, the answer is A."
        }
      ]
    },
    {
      "id":"medqa,2",
      "type":"mc",
      "conversations":[
        {
          "from":"human",
          "value":"A mother brings her 3-week-old infant to the pediatrician's office because she is concerned about his feeding habits. He was born without complications and has not had any medical problems up until this time. However, for the past 4 days, he has been fussy, is regurgitating all of his feeds, and his vomit is yellow in color. On physical exam, the child's abdomen is minimally distended but no other abnormalities are appreciated. Which of the following embryologic errors could account for this presentation?\n\nA. Abnormal migration of ventral pancreatic bud\nB. Complete failure of proximal duodenum to recanalize\nC. Abnormal hypertrophy of the pylorus\nD. Failure of lateral body folds to move ventrally and fuse in the midline"
        },
        {
          "from":"gpt",
          "value":"The answer is A."
        }
      ],
      "answer":"A",
      "model_outputs":[
        {
          "BioMistral-7B-Zephyr-Beta-SLERP_base":" The symptoms presented by the infant are regurgitation and vomiting, which could be related to an issue with the digestive system. Therefore, we need to focus on the embryology of the digestive system to find the answer.\n\nThe digestive system develops from the endoderm, which forms the lining of the gut tube. As the embryo grows, the gut tube begins to fold and twist, forming the structures of the digestive system. There are several embryologic errors that could result in the symptoms presented by the infant.\n\nA. Abnormal migration of ventral pancreatic bud: The pancreas develops from two buds, the dorsal and ventral pancreatic buds. The ventral pancreatic bud migrates ventrally and fuses with the dorsal pancreatic bud to form the head of the pancreas. If there is an abnormal migration of the ventral pancreatic bud, it could result in the head of the pancreas being located in an abnormal position. This could cause issues with digestion and lead to regurgitation and vomiting. However, this error would not typically cause yellow vomit, which eliminates this answer.\n\nB. Complete failure of proximal duodenum to recanalize: During embryonic development, the gut tube folds and twists to form the structures of the digestive system. The duodenum is formed by the recanalization of the primitive duodenum, which is a straight tube that initially forms. If there is a complete failure of the proximal duodenum to recanalize, it could result in an obstruction and cause regurgitation and vomiting. However, this error would not typically cause yellow vomit, which eliminates this answer.\n\nC. Abnormal hypertrophy of the pylorus: The pylorus is the muscular valve that connects the stomach to the duodenum. If there is abnormal hypertrophy of the pylorus, it could cause issues with digestion and lead to regurgitation and vomiting. However, this error would not typically cause yellow vomit, which eliminates this answer.\n\nD. Failure of lateral body folds to move ventrally and fuse in the midline: During embryonic development, the lateral body folds move ventrally and fuse in the midline to form the ventral body wall. If there is a failure of the lateral body folds to move ventrally and fuse in the midline, it could result in an obstruction of the digestive system and cause regurgitation and vomiting. However, this error would not typically cause yellow vomit, which eliminates this answer.\n\nSo, the answer is D."
        },
        {
          "med42-70b_base":" The infant is presenting with symptoms of vomiting, fussiness, and regurgitation, which could be indicative of a problem with the pancreas or duodenum. The abnormal migration of the ventral pancreatic bud could result in a blockage of the duodenum, leading to these symptoms. Therefore, the answer is A."
        },
        {
          "Mixtral-8x7B-Instruct-v0.1_base":" The symptoms described in the question are consistent with a blockage in the digestive system, specifically in the duodenum, which is the first part of the small intestine. This blockage prevents the stomach from emptying properly, causing the infant to regurgitate all of his feeds. The yellow color of the vomit suggests the presence of bile, which is produced by the liver and stored in the gallbladder, and only enters the small intestine after the stomach has emptied into the duodenum.\n\nThe embryologic error that could account for this presentation is a complete failure of the proximal duodenum to recanalize. During embryonic development, the digestive system starts as a tube that eventually forms the esophagus, stomach, small intestine, and large intestine. The duodenum is formed when the foregut and midgut connect and the connection later closes, leaving a small opening for food to pass through. If this opening fails to form or is too narrow, it can cause a blockage in the duodenum, leading to the symptoms described in the question.\n\nSo, the answer is B."
        },
        {
          "Qwen1.5-72B-Chat_base":"The symptoms described in the infant, such as fussiness, regurgitation of feeds, and yellow vomit, are consistent with a condition called pyloric stenosis. Pyloric stenosis is a condition where the muscle in the pylorus, the area between the stomach and the small intestine, becomes abnormally thickened (hypertrophied), leading to vomiting and difficulty in passing food from the stomach to the duodenum.\n\nGiven the options:\n\nA. Abnormal migration of ventral pancreatic bud - This would lead to pancreatic developmental issues, not vomiting and feeding difficulties in a newborn.\n\nB. Complete failure of proximal duodenum to recanalize - This would result in a blockage in the small intestine, but it is not the typical cause of the symptoms described.\n\nC. Abnormal hypertrophy of the pylorus - This is the correct answer, as it directly corresponds to pyloric stenosis, which matches the infant's presentation.\n\nD. Failure of lateral body folds to move ventrally and fuse in the midline - This would lead to a condition called omphalocele or gastroschisis, which are abdominal wall defects, not a feeding issue related to the stomach and duodenum.\n\nSo, the answer is C."
        },
        {
          "gpt-3.5-turbo-1106":"The symptoms described, including regurgitation of feeds and yellow vomit, are consistent with pyloric stenosis, a condition in which the muscle surrounding the pylorus (the outlet of the stomach) becomes abnormally thickened, leading to obstruction of the stomach. This condition is caused by abnormal hypertrophy of the pylorus, which is option C. This abnormality is not related to embryologic errors, but rather to a functional issue with the muscle itself.\n\nSo, the answer is C."
        },
        {
          "gpt-4-1106-preview":"The infant's symptoms of fussiness, regurgitation of feeds, and yellow-colored vomit suggest an obstruction in the gastrointestinal tract. The yellow color of the vomit indicates the presence of bile, which means the obstruction is likely to be distal to the ampulla of Vater where bile enters the duodenum.\n\nA. Abnormal migration of the ventral pancreatic bud can lead to pancreatic anomalies such as an annular pancreas, which can encircle and constrict the duodenum, but this typically presents with bilious vomiting soon after birth, not several weeks later.\n\nB. Complete failure of the proximal duodenum to recanalize would also present with bilious vomiting shortly after birth due to a complete obstruction of the duodenum.\n\nC. Abnormal hypertrophy of the pylorus is consistent with pyloric stenosis, which typically presents in infants around 3 to 5 weeks of age with projectile vomiting, which can be bilious if the obstruction is severe. The timing and symptoms align well with this condition.\n\nD. Failure of lateral body folds to move ventrally and fuse in the midline is associated with congenital abdominal wall defects, such as gastroschisis or omphalocele, and not with the symptoms described.\n\nBased on the information provided and the timing of symptom onset, the most likely embryologic error is abnormal hypertrophy of the pylorus, leading to pyloric stenosis.\n\nSo, the answer is C."
        }
      ]
    },
    {
      "id":"medqa,3",
      "type":"mc",
      "conversations":[
        {
          "from":"human",
          "value":"A pulmonary autopsy specimen from a 58-year-old woman who died of acute hypoxic respiratory failure was examined. She had recently undergone surgery for a fractured femur 3 months ago. Initial hospital course was uncomplicated, and she was discharged to a rehab facility in good health. Shortly after discharge home from rehab, she developed sudden shortness of breath and had cardiac arrest. Resuscitation was unsuccessful. On histological examination of lung tissue, fibrous connective tissue around the lumen of the pulmonary artery is observed. Which of the following is the most likely pathogenesis for the present findings?\n\nA. Thromboembolism\nB. Pulmonary ischemia\nC. Pulmonary hypertension\nD. Pulmonary passive congestion"
        },
        {
          "from":"gpt",
          "value":"The answer is A."
        }
      ],
      "answer":"A",
      "model_outputs":[
        {
          "BioMistral-7B-Zephyr-Beta-SLERP_base":" The patient had recently undergone surgery for a fractured femur and was discharged to a rehab facility in good health. Shortly after discharge home from rehab, she developed sudden shortness of breath and had cardiac arrest. Resuscitation was unsuccessful.\n\nOn histological examination of lung tissue, fibrous connective tissue around the lumen of the pulmonary artery is observed. Based on the patient's history and the pathological findings, the most likely pathogenesis for the present findings is pulmonary embolism (A). Pulmonary embolism is a blockage of a pulmonary artery by a blood clot that has traveled from another part of the body, usually the deep veins of the legs. It can cause sudden shortness of breath, chest pain, and cardiac arrest, which are symptoms that the patient experienced. The pathological finding of fibrous connective tissue around the lumen of the pulmonary artery is consistent with pulmonary embolism, as the clot can cause inflammation and scarring in the lung tissue. Pulmonary ischemia (B) and pulmonary hypertension (C) can also result from pulmonary embolism, but they are not the primary diagnosis in this case. Passive congestion (D) is a condition in which fluid accumulates in the lungs due to heart failure, but it does not involve the pulmonary arteries and is not consistent with the pathological finding observed in this patient. So, the answer is A."
        },
        {
          "med42-70b_base":" The answer is A."
        },
        {
          "Mixtral-8x7B-Instruct-v0.1_base":" The patient's history of recent surgery and sudden onset of shortness of breath suggest the possibility of a pulmonary embolism. Pulmonary embolism occurs when a clot or other material, often from the deep veins of the legs, travels to the lungs and blocks a pulmonary artery. This can lead to hypoxic respiratory failure, as seen in this patient.\n\nThe histological examination of lung tissue shows fibrous connective tissue around the lumen of the pulmonary artery. This is a characteristic finding of chronic pulmonary thromboembolism, where persistent occlusion of the pulmonary artery by a thrombus leads to the formation of fibrous tissue.\n\nTherefore, the most likely pathogenesis for the present findings is thromboembolism (option A).\n\nSo, the answer is A."
        },
        {
          "Qwen1.5-72B-Chat_base":"The histological finding of fibrous connective tissue around the lumen of the pulmonary artery is indicative of a process called intimal fibrosis, which is often associated with chronic pressure overload or injury to the vessel wall. \n\nA. Thromboembolism typically leads to obstruction of the pulmonary artery lumen by a clot, not necessarily causing fibrosis in the intima.\n\nB. Pulmonary ischemia refers to a lack of blood flow to the lungs, which would typically cause tissue damage and infarction, not specifically intimal fibrosis.\n\nC. Pulmonary hypertension, particularly the chronic form, can lead to intimal thickening and fibrosis as the vessel walls try to compensate for the increased pressure, resulting in remodeling of the pulmonary vasculature.\n\nD. Pulmonary passive congestion is a consequence of increased pressure in the left atrium, leading to blood backing up into the lung vessels. While it can cause congestion and edema, it is not the primary cause of intimal fibrosis.\n\nGiven the patient's history of recent surgery and subsequent sudden shortness of breath, followed by cardiac arrest, it's plausible that the patient developed pulmonary hypertension due to either a post-operative complication or as a consequence of her rehab and recovery. This hypertension could have led to the observed intimal fibrosis.\n\nSo, the answer is C."
        },
        {
          "gpt-3.5-turbo-1106":"The presence of fibrous connective tissue around the lumen of the pulmonary artery suggests chronic changes in the pulmonary vasculature. This is most likely due to pulmonary hypertension, which can lead to vascular remodeling and fibrosis. Pulmonary hypertension can result from a variety of causes, including chronic hypoxia, which may have been exacerbated by the patient's recent surgery and subsequent immobilization. The development of fibrous connective tissue around the pulmonary artery lumen is consistent with the pathogenesis of pulmonary hypertension.\n\nSo, the answer is C. Pulmonary hypertension"
        },
        {
          "gpt-4-1106-preview":"The clinical history of the patient includes a recent surgery (fractured femur) and a period of immobility during recovery at a rehab facility. The sudden onset of shortness of breath followed by cardiac arrest is highly suggestive of a pulmonary embolism, which is a common complication post-surgery due to thrombus formation during periods of immobility.\n\nHistological examination of the lung tissue showing fibrous connective tissue around the lumen of the pulmonary artery is indicative of an organized thrombus. Over time, a thrombus can become organized and recanalized, leading to the presence of fibrous connective tissue as the body attempts to restore patency to the vessel.\n\nPulmonary ischemia (B) is a condition that results from insufficient blood flow to the lung tissue, but it does not typically cause fibrous connective tissue formation around the pulmonary artery.\n\nPulmonary hypertension (C) is a condition characterized by increased pressure in the pulmonary arteries, which can lead to remodeling of the vessel walls, but the acute presentation in this case is not typical of pulmonary hypertension.\n\nPulmonary passive congestion (D) is a condition that occurs due to left heart failure leading to increased pressure in the pulmonary circulation. This can cause congestion and edema but would not typically cause the formation of fibrous connective tissue around the pulmonary artery.\n\nConsidering the patient's history and the histological findings, the most likely pathogenesis for the observed lung changes is thromboembolism, which occurs when a blood clot that has formed elsewhere in the body (often in the deep veins of the legs, known as deep vein thrombosis) breaks loose and travels to the lungs, causing a blockage.\n\nSo, the answer is A."
        }
      ]
    },
    {
      "id":"medqa,5",
      "type":"mc",
      "conversations":[
        {
          "from":"human",
          "value":"A 40-year-old zookeeper presents to the emergency department complaining of severe abdominal pain that radiates to her back, and nausea. The pain started 2 days ago and slowly increased until she could not tolerate it any longer. Past medical history is significant for hypertension and hypothyroidism. Additionally, she reports that she was recently stung by one of the zoo\u2019s smaller scorpions, but did not seek medical treatment. She takes aspirin, levothyroxine, oral contraceptive pills, and a multivitamin daily. Family history is noncontributory. Today, her blood pressure is 108/58 mm Hg, heart rate is 99/min, respiratory rate is 21/min, and temperature is 37.0\u00b0C (98.6\u00b0F). On physical exam, she is a well-developed, obese female that looks unwell. Her heart has a regular rate and rhythm. Radial pulses are weak but symmetric. Her lungs are clear to auscultation bilaterally. Her lateral left ankle is swollen, erythematous, and painful to palpate. An abdominal CT is consistent with acute pancreatitis. Which of the following is the most likely etiology for this patient\u2019s disease?\n\nA. Aspirin\nB. Oral contraceptive pills\nC. Scorpion sting\nD. Hypothyroidism"
        },
        {
          "from":"gpt",
          "value":"The answer is C."
        }
      ],
      "answer":"C",
      "model_outputs":[
        {
          "BioMistral-7B-Zephyr-Beta-SLERP_base":" The patient presents with severe abdominal pain that radiates to her back, and nausea. The pain started 2 days ago and slowly increased until she could not tolerate it any longer. Additionally, she reports that she was recently stung by one of the zoo\u2019s smaller scorpions, but did not seek medical treatment. On physical exam, she has a swollen, erythematous, and painful left ankle. An abdominal CT is consistent with acute pancreatitis. Based on this information, the most likely etiology for this patient's disease is the scorpion sting. The scorpion sting could have caused an allergic reaction that led to acute pancreatitis, as well as the ankle swelling and inflammation. While the other factors (aspirin, oral contraceptive pills, hypothyroidism) may have contributed to her overall health status, they are less likely to be the direct cause of her current symptoms. Therefore, the most likely etiology for this patient's disease is the scorpion sting.\n\nSo, the answer is C."
        },
        {
          "med42-70b_base":" The most likely etiology for this patient's acute pancreatitis is the recent scorpion sting. Scorpion stings can cause a variety of symptoms, including pain, swelling, and difficulty breathing. In some cases, they can also lead to more serious complications, such as pancreatitis. While aspirin, oral contraceptive pills, and hypothyroidism can all be associated with pancreatitis, there is no evidence in this case to suggest that they played a role in the development of the patient's condition."
        },
        {
          "Mixtral-8x7B-Instruct-v0.1_base":" The patient's symptoms of severe abdominal pain radiating to her back and nausea, along with the CT scan results consistent with acute pancreatitis, require us to find a cause that could lead to pancreatitis.\n\nA: Aspirin - While aspirin can sometimes cause gastrointestinal side effects, it is not a common cause of pancreatitis. Moreover, the patient has been taking aspirin for a long time, and the onset of symptoms occurred only 2 days ago, making aspirin less likely as the cause.\n\nB: Oral contraceptive pills - Although oral contraceptives have been linked to pancreatitis in rare cases, the patient's symptoms starting just 2 days ago and the absence of any other risk factors suggest that this is not the most likely cause.\n\nC: Scorpion sting - Scorpion venom can cause a variety of symptoms, including severe pain, but direct pancreatic injury from scorpion stings is not well-documented. Additionally, the venom would have to reach the pancreas through the bloodstream, which is unlikely.\n\nD: Hypothyroidism - Hypothyroidism is not a common cause of pancreatitis. However, it is essential to note that the patient has recently been stung by a scorpion. Scorpion venom can cause the release of large amounts of catecholamines, which can, in turn, trigger a surge in thyroid hormone levels. This phenomenon is called a \"pancreatic surge\" or \"pancreatic push,\" which might cause acute pancreatitis in susceptible individuals.\n\nSo, the answer is D."
        },
        {
          "Qwen1.5-72B-Chat_base":"Acute pancreatitis is typically caused by one of two main factors: gallstones or alcohol consumption. However, there are other less common causes as well.\n\nA. Aspirin: Nonsteroidal anti-inflammatory drugs (NSAIDs), including aspirin, can cause acute pancreatitis, especially with long-term or high-dose use. However, it is not the most common cause.\n\nB. Oral contraceptive pills: These have been implicated in causing pancreatitis, but it is a rare side effect and not a leading cause.\n\nC. Scorpion sting: While scorpion venom can have various effects on the body, including neurological symptoms, it is not a well-established cause of acute pancreatitis. It is also a less common and less likely explanation in this case.\n\nD. Hypothyroidism: Hypothyroidism is not typically associated with acute pancreatitis. It may contribute to other health issues, but it is not a common cause of this specific condition.\n\nGiven the patient's history, recent scorpion sting, and the absence of other more common causes like gallstones or alcohol consumption, the scorpion sting stands out as the most likely etiology for her acute pancreatitis, especially considering the time frame between the sting and the onset of symptoms.\n\nSo, the answer is C."
        },
        {
          "gpt-3.5-turbo-1106":"First, the patient's symptoms of severe abdominal pain radiating to her back, nausea, and recent scorpion sting point towards acute pancreatitis. The fact that she was stung by a scorpion and did not seek medical treatment suggests that the scorpion venom could have contributed to the development of pancreatitis. Additionally, her hypotension and weak radial pulses are indicative of hypovolemic shock, which can occur as a result of pancreatitis.\n\nTherefore, the most likely etiology for this patient\u2019s disease is C. Scorpion sting.\n\nSo, the answer is C."
        },
        {
          "gpt-4-1106-preview":"The patient presents with severe abdominal pain radiating to the back and nausea, which are classic symptoms of acute pancreatitis. The abdominal CT confirms this diagnosis. Now, let's consider the potential etiologies presented:\n\nA. Aspirin - While aspirin can cause gastrointestinal upset, it is not a common cause of acute pancreatitis.\n\nB. Oral contraceptive pills - Use of oral contraceptive pills has been associated with an increased risk of acute pancreatitis. The estrogen component can lead to hypertriglyceridemia, which is a risk factor for pancreatitis.\n\nC. Scorpion sting - Scorpion stings can cause a variety of systemic symptoms, but they are not a common cause of acute pancreatitis. However, in rare cases, severe scorpion envenomation can lead to pancreatitis due to the release of pancreatic enzymes.\n\nD. Hypothyroidism - Hypothyroidism can lead to hypertriglyceridemia, which is a risk factor for pancreatitis, but it is not the most common cause when compared to factors like gallstones, alcohol use, or medications.\n\nGiven the patient's use of oral contraceptive pills and the absence of other more common risk factors such as alcohol use or gallstones (not mentioned in the case), the oral contraceptive pills are the most likely etiology for her acute pancreatitis.\n\nSo, the answer is B."
        }
      ]
    },
    {
      "id":"medqa,6",
      "type":"mc",
      "conversations":[
        {
          "from":"human",
          "value":"A 25-year-old primigravida presents to her physician for a routine prenatal visit. She is at 34 weeks gestation, as confirmed by an ultrasound examination. She has no complaints, but notes that the new shoes she bought 2 weeks ago do not fit anymore. The course of her pregnancy has been uneventful and she has been compliant with the recommended prenatal care. Her medical history is unremarkable. She has a 15-pound weight gain since the last visit 3 weeks ago. Her vital signs are as follows: blood pressure, 148/90 mm Hg; heart rate, 88/min; respiratory rate, 16/min; and temperature, 36.6\u2103 (97.9\u2109). The blood pressure on repeat assessment 4 hours later is 151/90 mm Hg. The fetal heart rate is 151/min. The physical examination is significant for 2+ pitting edema of the lower extremity. Which of the following tests o should confirm the probable condition of this patient?\n\nA. Bilirubin assessment\nB. Coagulation studies\nC. Leukocyte count with differential\nD. 24-hour urine protein"
        },
        {
          "from":"gpt",
          "value":"The answer is D."
        }
      ],
      "answer":"D",
      "model_outputs":[
        {
          "BioMistral-7B-Zephyr-Beta-SLERP_base":" Firstly, the patient has edema which is a sign of fluid retention. This could be due to various reasons like heart failure, kidney disease, liver disease, or pregnancy. The patient's weight gain is higher than recommended, but this alone cannot explain the edema. The patient's blood pressure is high but not extremely high to cause heart failure or kidney disease. Therefore, the most likely reason for edema in this case is pregnancy-induced hypertension. The patient's other symptoms like headache and visual disturbances suggest that she might be developing preeclampsia, which is a severe form of pregnancy-induced hypertension. Therefore, it is essential to confirm the diagnosis of preeclampsia to ensure appropriate management. The test that confirms preeclampsia is a 24-hour urine protein test, which measures the amount of protein excreted in the urine over a 24-hour period. If the amount of protein excreted is more than 300 mg in 24 hours, it is considered positive for preeclampsia. So, the answer is D."
        },
        {
          "med42-70b_base":" The patient's presentation of rapidly progressing edema, significant weight gain, and elevated blood pressure, along with the fetal tachycardia, is suggestive of preeclampsia. This diagnosis should be confirmed with additional testing, including a 24-hour urine protein measurement to assess for proteinuria. Other laboratory tests that may be helpful in the diagnosis and/or management of preeclampsia include serum creatinine, liver function tests, platelet count, and coagulation studies. Bilirubin assessment is usually not used to confirm or rule out preeclampsia. A leukocyte count with differential is unlikely to provide information relevant to the diagnosis of preeclampsia. A glucose measurement may be part of routine prenatal care, but is not specific for the diagnosis of preeclampsia. So, the answer is D."
        },
        {
          "Mixtral-8x7B-Instruct-v0.1_base":" The patient is a 25-year-old primigravida at 34 weeks gestation with an uneventful pregnancy history. However, she has gained 15 pounds in the past 3 weeks, has new-onset peripheral edema, and her blood pressure is elevated at 148/90 mm Hg, which increased to 151/90 mm Hg on repeat assessment. The fetal heart rate is 151/min. These findings suggest preeclampsia, a pregnancy complication characterized by hypertension and proteinuria or other end-organ dysfunction.\n\nTo confirm the diagnosis, we need to evaluate for proteinuria. Therefore, the best test to confirm the probable condition of this patient is:\n\nD. 24-hour urine protein\n\nSo, the answer is D."
        },
        {
          "Qwen1.5-72B-Chat_base":"The patient is a 25-year-old primigravida at 34 weeks gestation who has experienced a significant weight gain (15 pounds in 3 weeks) and now presents with elevated blood pressure (148/90 mm Hg and 151/90 mm Hg), pitting edema of the lower extremities, and a normal fetal heart rate. These symptoms are indicative of possible preeclampsia, a pregnancy-related condition characterized by hypertension and proteinuria.\n\nTo confirm the presence of preeclampsia, the key diagnostic test is to measure the amount of protein in the urine, as this is a hallmark sign of the condition. Therefore, the most appropriate test in this scenario is:\n\nD. 24-hour urine protein\n\nThis test will quantify the amount of protein excreted in the urine over a 24-hour period, and if the level is elevated, it would support the diagnosis of preeclampsia.\n\nSo, the answer is D."
        },
        {
          "gpt-3.5-turbo-1106":"The patient is presenting with new-onset edema, elevated blood pressure, and proteinuria, which are all signs of preeclampsia. Given her symptoms and the gestational age, the most appropriate test to confirm the probable condition of this patient would be a 24-hour urine protein to assess for proteinuria, which is a key diagnostic criterion for preeclampsia.\n\nSo, the answer is D. 24-hour urine protein"
        },
        {
          "gpt-4-1106-preview":"The patient is presenting with new-onset hypertension (blood pressure of 148/90 mm Hg and 151/90 mm Hg on two separate occasions) and significant weight gain over a short period, which could be indicative of fluid retention. Additionally, she has 2+ pitting edema of the lower extremity. These findings are concerning for preeclampsia, which is a condition that can occur in pregnancy after 20 weeks gestation and is characterized by new-onset hypertension and either proteinuria or other signs of end-organ dysfunction.\n\nPreeclampsia is a serious condition that can have adverse effects on both the mother and the fetus. The diagnosis of preeclampsia is based on the presence of hypertension and proteinuria, typically defined as the excretion of 300 mg or more of protein in a 24-hour urine sample. Therefore, the most appropriate test to confirm the probable condition of this patient would be a 24-hour urine protein to assess for proteinuria.\n\nSo, the answer is D."
        }
      ]
    },
    {
      "id":"medqa,8",
      "type":"mc",
      "conversations":[
        {
          "from":"human",
          "value":"A 62-year-old woman presents for a regular check-up. She complains of lightheadedness and palpitations which occur episodically. Past medical history is significant for a myocardial infarction 6 months ago and NYHA class II chronic heart failure. She also was diagnosed with grade I arterial hypertension 4 years ago. Current medications are aspirin 81 mg, atorvastatin 10 mg, enalapril 10 mg, and metoprolol 200 mg daily. Her vital signs are a blood pressure of 135/90 mm Hg, a heart rate of 125/min, a respiratory rate of 14/min, and a temperature of 36.5\u00b0C (97.7\u00b0F). Cardiopulmonary examination is significant for irregular heart rhythm and decreased S1 intensity. ECG is obtained and is shown in the picture (see image). Echocardiography shows a left ventricular ejection fraction of 39%. Which of the following drugs is the best choice for rate control in this patient?\n\nA. Atenolol\nB. Diltiazem\nC. Propafenone\nD. Digoxin"
        },
        {
          "from":"gpt",
          "value":"The answer is D."
        }
      ],
      "answer":"D",
      "model_outputs":[
        {
          "BioMistral-7B-Zephyr-Beta-SLERP_base":" Firstly, we need to determine whether the patient has atrial fibrillation (AF). Based on her symptoms of lightheadedness and palpitations, and the irregular heart rhythm on her ECG, it is likely that she has AF. Secondly, we need to consider the other conditions that can cause irregular heart rhythm in this patient. She had a myocardial infarction six months ago, which can lead to AF. However, her ejection fraction is only 39%, which is considered moderate to severe heart failure. Therefore, it is more likely that her AF is due to her heart failure rather than her history of myocardial infarction. Thirdly, we need to consider the patient's other medical conditions. She has hypertension and chronic heart failure, which can both contribute to the development of AF. Finally, we need to consider the patient's current medications. She is taking metoprolol, which is a beta-blocker that can help control her heart rate. However, beta-blockers are not as effective in controlling heart rate in patients with heart failure as they are in patients without heart failure. Therefore, it is likely that she still experiences episodes of tachycardia.\n\nBased on all of the above considerations, the best choice for rate control in this patient is digoxin. Digoxin is effective in controlling heart rate in patients with heart failure, and it can also help improve cardiac output and reduce symptoms of heart failure. Atenolol is not the best choice because it is less effective in controlling heart rate in patients with heart failure than in patients without heart failure. Diltiazem is not the best choice because it can cause an increase in heart rate in patients with heart failure. Propafenone is not the best choice because it can cause an increase in heart rate in patients with heart failure."
        },
        {
          "med42-70b_base":" The patient in the question has atrial fibrillation with rapid ventricular response, a history of myocardial infarction, chronic heart failure, and hypertension. She is currently on medications that include enalapril, metoprolol, aspirin, and atorvastatin. The ECG shows atrial fibrillation with a rapid ventricular response, and the echocardiogram reveals a left ventricular ejection fraction of 39%. \n\nIn this case, rate control is necessary to prevent a rapid ventricular response from causing further cardiac events. The options provided are atenolol, diltiazem, propafenone, and digoxin. Atenolol is a beta-blocker that can be used for rate control in patients with atrial fibrillation. Diltiazem is a calcium channel blocker that can also be used for rate control, but it is not as effective as beta-blockers. Propafenone is another beta-blocker that can be used for rate control, but it is not as well-tolerated as atenolol. Digoxin is not a preferred drug for rate control in patients with atrial fibrillation. \n\nTherefore, the best choice for rate control in this patient is atenolol."
        },
        {
          "Mixtral-8x7B-Instruct-v0.1_base":" The patient is a 62-year-old woman with a history of myocardial infarction, chronic heart failure, and arterial hypertension. She is experiencing lightheadedness and palpitations, and her ECG shows atrial fibrillation with a rapid ventricular response. The goal in managing atrial fibrillation is to control the ventricular rate and prevent thromboembolism.\n\nFor rate control, we want to choose a medication that slows the ventricular response to atrial fibrillation while also being safe for patients with heart failure and arterial hypertension.\n\nLet's consider each of the options:\n\nA. Atenolol is a beta-blocker that can be used for rate control in atrial fibrillation. However, it is not a first-line choice for patients with heart failure as it can worsen symptoms.\n\nB. Diltiazem is a calcium channel blocker that can slow the ventricular response to atrial fibrillation. It is also safe for patients with heart failure and arterial hypertension.\n\nC. Propafenone is an antiarrhythmic medication that can be used to convert atrial fibrillation to sinus rhythm. However, it is contraindicated in patients with heart failure as it can worsen symptoms.\n\nD. Digoxin is a medication that can be used for rate control in atrial fibrillation. It is safe for patients with heart failure and arterial hypertension. However, its effect on rate control is less reliable than other medications.\n\nBased on these considerations, the best choice for rate control in this patient is likely B. Diltiazem. It is a safe and effective medication for rate control in atrial fibrillation and is well-tolerated in patients with heart failure and arterial hypertension.\n\nSo, the answer is B."
        },
        {
          "Qwen1.5-72B-Chat_base":"The patient is a 62-year-old woman with a history of myocardial infarction, chronic heart failure (NYHA class II), arterial hypertension, and is currently experiencing lightheadedness and palpitations. Her heart rate is elevated at 125/min, and her ECG shows an irregular rhythm, which is likely atrial fibrillation or atrial flutter given the context. The decreased S1 intensity on examination further supports this. Echocardiography reveals a left ventricular ejection fraction of 39%, indicating impaired cardiac function.\n\nThe goal here is to control the patient's rapid heart rate for rate control in atrial fibrillation or atrial flutter. The best choice for rate control in such a patient with heart failure would be a drug that is safe in this setting and has a positive impact on cardiac function.\n\nA. Atenolol is a beta-blocker, which can be effective in rate control, but it may exacerbate heart failure in some patients.\n\nB. Diltiazem is a calcium channel blocker. It is effective in rate control and is often preferred in patients with heart failure\u56e0\u4e3a\u5b83\u53ef\u4ee5\u6539\u5584\u5fc3\u5ba4\u7684\u5145\u76c8\u548c\u5fc3\u808c\u8017\u6c27\u91cf\u3002\n\nC. Propafenone is a class Ic antiarrhythmic drug, which is not typically the first choice for rate control in heart failure patients due to its potential negative inotropic effect and proarrhythmic risks.\n\nD. Digoxin is a digitalis glycoside that can help with rate control, but it has a narrow therapeutic window and can be associated with adverse effects, especially in heart failure patients.\n\nConsidering the patient's history of heart failure, the best choice for rate control would be a drug that is safe and effective in this population.\n\nSo, the answer is B."
        },
        {
          "gpt-3.5-turbo-1106":"The patient is presenting with lightheadedness and palpitations, which are suggestive of arrhythmias. Her ECG shows atrial fibrillation with a rapid ventricular response, indicated by the irregularly irregular rhythm and a heart rate of 125/min. Given her history of chronic heart failure and recent myocardial infarction, it is important to control her heart rate to prevent further deterioration of her cardiac function.\n\nIn this case, the best choice for rate control would be diltiazem. Diltiazem is a calcium channel blocker that can effectively slow down the heart rate in patients with atrial fibrillation. It is particularly beneficial in patients with heart failure, as it does not have the negative inotropic effects seen with beta-blockers.\n\nSo, the answer is B. Diltiazem"
        },
        {
          "gpt-4-1106-preview":"The patient presents with symptoms of lightheadedness and palpitations, which are episodic in nature. Given her history of myocardial infarction and chronic heart failure, she is at an increased risk for arrhythmias. The irregular heart rhythm and decreased S1 intensity on examination, along with the ECG findings, are suggestive of atrial fibrillation (AF).\n\nThe goal in the management of AF is to provide rate control or rhythm control. Rate control is often the first-line treatment, especially in patients who are hemodynamically stable. This patient's left ventricular ejection fraction is 39%, which indicates she has a reduced ejection fraction and falls under the category of heart failure with reduced ejection fraction (HFrEF).\n\nThe medications for rate control in AF with HFrEF include beta-blockers and non-dihydropyridine calcium channel blockers. However, non-dihydropyridine calcium channel blockers like diltiazem (option B) should be avoided in patients with HFrEF as they can exacerbate heart failure.\n\nThe patient is already on metoprolol, which is a beta-blocker, but her heart rate is still elevated at 125/min. It's possible that her current dose of metoprolol is not sufficient for rate control, but switching to another beta-blocker such as atenolol (option A) would not be the best choice given that she might benefit from a higher dose or different management strategy with her current medication.\n\nPropafenone (option C) is a class IC antiarrhythmic and is used for rhythm control, not rate control. It is also contraindicated in patients with structural heart disease like the one this patient has.\n\nDigoxin (option D) is a reasonable choice for rate control in patients with AF and heart failure, as it can help control the ventricular rate by increasing vagal tone and decreasing conduction through the AV node. It is particularly useful in patients who cannot tolerate or do not achieve rate control with beta-blockers.\n\nGiven the patient's history of heart failure and the need for rate control, digoxin is a suitable option to add to her current regimen.\n\nSo, the answer is D."
        }
      ]
    },
    {
      "id":"medqa,9",
      "type":"mc",
      "conversations":[
        {
          "from":"human",
          "value":"A 35-year-old male presents to his primary care physician with complaints of seasonal allergies. He has been using intranasal vasoconstrictors several times per day for several weeks. What is a likely sequela of the chronic use of topical nasal decongestants?\n\nA. Epistaxis\nB. Permanent loss of smell\nC. Persistent nasal crusting\nD. Persistent congestion"
        },
        {
          "from":"gpt",
          "value":"The answer is D."
        }
      ],
      "answer":"D",
      "model_outputs":[
        {
          "BioMistral-7B-Zephyr-Beta-SLERP_base":" When someone has allergies, they may use over-the-counter (OTC) medications such as nasal decongestants to alleviate their symptoms. Nasal decongestants work by constricting the blood vessels in the nasal mucosa, which reduces swelling and congestion. However, chronic use of nasal decongestants can lead to rebound congestion, which is when the blood vessels become even more dilated than before using the medication. This can result in persistent nasal congestion, even when the medication is not being used. Rebound congestion can also make the nasal passages more prone to infection and can lead to other complications such as epistaxis (nosebleeds). Additionally, chronic use of nasal decongestants can cause permanent loss of smell in some people, although this is less common. Therefore, it is generally recommended to use nasal decongestants for no more than a few days at a time, and to consult a healthcare provider if symptoms persist. So, the answer is C."
        },
        {
          "med42-70b_base":" Chronic use of topical nasal decongestants can lead to a condition called rhinitis medicamentosa. This is a type of non-allergic rhinitis that occurs when the nasal tissues become dependent on the decongestant to maintain their normal size and shape. When the decongestant is stopped, the nasal tissues swell, leading to symptoms of congestion. Persistent congestion is the most common symptom of rhinitis medicamentosa. Other symptoms can include nasal dryness, crusting, and bleeding. Therefore, the correct answer is D."
        },
        {
          "Mixtral-8x7B-Instruct-v0.1_base":" Chronic use of topical nasal decongestants can lead to a condition called rhinitis medicamentosa, which is essentially rebound congestion caused by overuse of these medications. The nasal passages become dependent on the decongestant to maintain normal blood flow and tissue size, so when the medication is stopped, the nasal passages experience increased swelling and congestion.\n\nSo, the answer is D."
        },
        {
          "Qwen1.5-72B-Chat_base":"Chronic use of topical nasal decongestants, such as intranasal vasoconstrictors, can lead to a condition called \"rebound congestion\" or \"rhinitis medicamentosa.\" This occurs when the nasal blood vessels become tolerant to the decongestant and start to hyperreact, causing congestion when the medication is stopped or its effect wears off. \n\nA. Epistaxis (nosebleeds) can be a potential side effect of chronic use, as the vasoconstriction and subsequent rebound dilation of blood vessels in the nose can weaken the nasal mucosa and make it more prone to bleeding.\n\nB. Permanent loss of smell (anosmia) is not a direct and typical sequela of chronic use of topical nasal decongestants, although prolonged congestion can temporarily affect the sense of smell.\n\nC. Persistent nasal crusting can occur due to the drying effect of the decongestants on the nasal mucosa, but it is not the most likely primary sequela.\n\nD. Persistent congestion is actually the most characteristic consequence of rebound congestion, as the body becomes dependent on the medication to maintain nasal patency.\n\nSo, the answer is D."
        },
        {
          "gpt-3.5-turbo-1106":"Chronic use of intranasal vasoconstrictors can lead to rebound congestion, where the nasal passages become even more congested when the medication wears off. This can result in persistent congestion and nasal crusting. Additionally, chronic use can also lead to damage to the nasal mucosa, increasing the risk of epistaxis (nosebleeds). Permanent loss of smell can also occur as a result of chronic nasal decongestant use. Therefore, the likely sequela of chronic use of topical nasal decongestants is a combination of A, C, and D. So, the answer is A, C, and D."
        },
        {
          "gpt-4-1106-preview":"The chronic use of topical nasal decongestants, such as intranasal vasoconstrictors, can lead to a condition known as rhinitis medicamentosa. This condition is characterized by rebound congestion caused by the downregulation of adrenergic receptors in the nasal mucosa due to the prolonged use of these medications. When the effect of the vasoconstrictor wears off, the blood vessels in the nasal passages dilate more than before, leading to worsening congestion.\n\nEpistaxis (A) can occur due to the drying effect of the nasal spray, but it is not as common a sequela of chronic use as rebound congestion. Permanent loss of smell (B) is unlikely to be directly caused by the use of nasal decongestants. Persistent nasal crusting (C) can occur due to the drying effect of the medication, but it is not the primary concern with chronic use.\n\nThe most likely sequela of the chronic use of topical nasal decongestants is persistent congestion (D), which is essentially the rebound effect causing the patient to use the medication more frequently, potentially leading to a vicious cycle.\n\nSo, the answer is D."
        }
      ]
    },
    {
      "id":"medqa,10",
      "type":"mc",
      "conversations":[
        {
          "from":"human",
          "value":"A 46-year-old woman comes to the physician because of a 2-week history of diplopia and ocular pain when reading the newspaper. She also has a 3-month history of amenorrhea, hot flashes, and increased sweating. She reports that she has been overweight all her adult life and is happy to have lost 6.8-kg (15-lb) of weight in the past 2 months. Her pulse is 110/min, and blood pressure is 148/98 mm Hg. Physical examination shows moist palms and a nontender thyroid gland that is enlarged to two times its normal size. Ophthalmologic examination shows prominence of the globes of the eyes, bilateral lid retraction, conjunctival injection, and an inability to converge the eyes. There is no pain on movement of the extraocular muscles. Visual acuity is 20/20 bilaterally. Neurologic examination shows a fine resting tremor of the hands. Deep tendon reflexes are 3+ with a shortened relaxation phase. Which of the following is the most likely cause of this patient's ocular complaints?\n\nA. Granulomatous inflammation of the cavernous sinus\nB. Abnormal communication between the cavernous sinus and the internal carotid artery\nC. Glycosaminoglycan accumulation in the orbit\nD. Sympathetic hyperactivity of levator palpebrae superioris\n\""
        },
        {
          "from":"gpt",
          "value":"The answer is C."
        }
      ],
      "answer":"C",
      "model_outputs":[
        {
          "BioMistral-7B-Zephyr-Beta-SLERP_base":" The patient is experiencing diplopia, ocular pain, lid retraction, conjunctival injection, and inability to converge the eyes. These symptoms are indicative of an ophthalmologic disorder. The fact that she has a history of weight loss, amenorrhea, hot flashes, and increased sweating suggests that she may be experiencing menopause. However, the symptoms she is experiencing are not typical of menopause alone. The fact that she has a history of being overweight all her adult life and has recently lost weight suggests that she may have thyroid dysfunction. The patient's thyroid gland is enlarged, moist palms, fine resting tremor, and shortened relaxation phase of deep tendon reflexes are all signs of thyroid dysfunction. The most likely cause of this patient's ocular complaints is glycosaminoglycan accumulation in the orbit due to thyroid dysfunction. [So, the answer is C.]"
        },
        {
          "med42-70b_base":" The most likely cause of this patient's ocular complaints is glycosaminoglycan accumulation in the orbit. The patient's symptoms of diplopia, ocular pain, and proptosis are suggestive of Graves' ophthalmopathy, which is an autoimmune condition that affects the thyroid gland and can cause the deposition of glycosaminoglycans in the extraocular muscles and connective tissues of the orbit. This can lead to inflammation, swelling, and compression of the optic nerve. The other answer choices are not related to the patient's symptoms or medical history."
        },
        {
          "Mixtral-8x7B-Instruct-v0.1_base":" The patient is experiencing diplopia (double vision) and ocular pain when reading, which suggests a problem with the eye muscles or nerves. The additional symptoms of amenorrhea, hot flashes, increased sweating, and weight loss suggest a hormonal imbalance, possibly due to hyperthyroidism. The physical examination supports this diagnosis, with moist palms and an enlarged thyroid gland.\n\nThe ophthalmologic examination reveals signs of proptosis (prominence of the globes of the eyes), lid retraction, conjunctival injection, and difficulty with convergence. These symptoms are consistent with a condition called thyroid eye disease (TED), which is often associated with hyperthyroidism. TED is caused by glycosaminoglycan accumulation in the orbit, which leads to inflammation, swelling, and pressure on the eye muscles and nerves.\n\nTherefore, the most likely cause of the patient's ocular complaints is C. Glycosaminoglycan accumulation in the orbit.\n\nSo, the answer is C."
        },
        {
          "Qwen1.5-72B-Chat_base":"The patient presents with a combination of symptoms and examination findings that point towards a specific disorder. Key ocular symptoms include diplopia (double vision), ocular pain with reading, globe prominence, lid retraction, conjunctival injection, and inability to converge the eyes. These symptoms, along with a nontender enlarged thyroid gland, weight loss, amenorrhea, hot flashes, and a fine resting tremor of the hands, suggest a hyperthyroid condition, specifically Graves' disease.\n\nGraves' disease is an autoimmune disorder that leads to hyperthyroidism and can cause orbitopathy, also known as Graves' ophthalmopathy. This orbitopathy affects the extraocular muscles and surrounding tissue, leading to the symptoms described.\n\nA. Granulomatous inflammation of the cavernous sinus is not typically associated with the described symptoms.\nB. Abnormal communication between the cavernous sinus and the internal carotid artery is not directly related to the symptoms of Graves' ophthalmopathy.\nC. Glycosaminoglycan accumulation in the orbit can be a feature of Graves' ophthalmopathy but is not the primary cause of the patient's ocular complaints; it's a consequence of the autoimmune response in Graves' disease.\nD. Sympathetic hyperactivity of levator palpebrae superioris could contribute to lid retraction but is not the main cause of the comprehensive set of ocular symptoms.\n\nGiven the context and the comprehensive presentation, the most likely cause of the patient's ocular complaints is due to the effects of Graves' disease on the orbit.\n\nSo, the answer is D."
        },
        {
          "gpt-3.5-turbo-1106":"The patient's symptoms of diplopia, ocular pain, lid retraction, and inability to converge the eyes are consistent with Graves' ophthalmopathy, which is commonly associated with Graves' disease. The patient's symptoms of amenorrhea, hot flashes, increased sweating, weight loss, tachycardia, and hypertension are also consistent with hyperthyroidism, which is often caused by Graves' disease. The physical examination findings of an enlarged thyroid gland, moist palms, and fine resting tremor of the hands further support the diagnosis of Graves' disease.\n\nGraves' ophthalmopathy is characterized by an autoimmune-mediated inflammation of the orbital tissues, including the extraocular muscles and the retro-orbital fat. This leads to the characteristic eye signs seen in this patient, such as lid retraction, conjunctival injection, and inability to converge the eyes.\n\nSo, the answer is C. Glycosaminoglycan accumulation in the orbit."
        },
        {
          "gpt-4-1106-preview":"The patient presents with signs and symptoms that are highly suggestive of hyperthyroidism, possibly due to Graves' disease. These include weight loss despite being overweight, increased sweating, hot flashes, amenorrhea, tachycardia (pulse of 110/min), hypertension (blood pressure of 148/98 mm Hg), moist palms, an enlarged thyroid gland, and a fine resting tremor. The shortened relaxation phase of the deep tendon reflexes is also consistent with hyperthyroidism.\n\nThe ocular symptoms, including diplopia, ocular pain when reading, prominence of the globes (proptosis or exophthalmos), bilateral lid retraction, conjunctival injection, and an inability to converge the eyes, are characteristic of Graves' ophthalmopathy. This condition is associated with immune-mediated inflammation and accumulation of glycosaminoglycans in the orbit and extraocular muscles, leading to increased orbital tissue volume and subsequent eye manifestations.\n\nThe options provided are:\n\nA. Granulomatous inflammation of the cavernous sinus - This would more likely cause painful ophthalmoplegia, which is not present in this case.\n\nB. Abnormal communication between the cavernous sinus and the internal carotid artery - This would potentially lead to a carotid-cavernous fistula, which is not indicated by the symptoms described.\n\nC. Glycosaminoglycan accumulation in the orbit - This is the pathophysiological mechanism behind Graves' ophthalmopathy, which matches the patient's presentation.\n\nD. Sympathetic hyperactivity of levator palpebrae superioris - While sympathetic hyperactivity might cause some of the symptoms like lid retraction, it does not explain the full spectrum of ocular findings nor the systemic symptoms of hyperthyroidism.\n\nGiven the clinical picture and the likely diagnosis of Graves' disease with ophthalmopathy, the most probable cause of the ocular complaints is the accumulation of glycosaminoglycans in the orbit.\n\nSo, the answer is C."
        }
      ]
    }
]